Author:
Welters M J P,Fichtinger-Schepman A M J,Baan R A,Jacobs-Bergmans A J,Kegel A,van der Vijgh W J F,Braakhuis B J M
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Braakhuis, B. J. M., Ruiz van Haperen, V. W. T., Welters, M. J. P. & Peters, G. J. (1995). Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts. Eur J Cancer 31A: 2335–2340.
2. Burnouf, D., Daune, M. & Fuchs, R. P. P. (1987). Spectrum of cisplatin-induced mutations in Escherichia coli. Proc Natl Acad Sci USA 84: 3758–3762.
3. Carey, T. E., Wolf, G. T., Baker, S. R. & Krause, C. J. (1990). Cell surface antigen expression and prognosis. Head and Neck Cancer, 2, Fee WE, Goepfert H, Johns ME, Ward PH (eds). 77–82, BC Decker: Toronto
4. Eastman, A. (1986). Reevaluation of interaction of cis-dichloro(ethylenediammine)-platinum(II) with DNA. Biochemistry 25: 3912–3915.
5. Fichtinger-Schepman, A. M. J., Van der veer, J. L., Den Hertog, J. H. J., Lohman, P. H. M. & Reedijk, J. (1985). Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 24: 707–713.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献